Literature DB >> 28172348

ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.

Vojtech Bystry1, Tomas Reigl1, Adam Krejci1,2, Martin Demko1, Barbora Hanakova1, Andrea Grioni1,3, Henrik Knecht4, Max Schlitt4, Peter Dreger5, Leopold Sellner5, Dietrich Herrmann4, Marine Pingeon6, Myriam Boudjoghra6, Jos Rijntjes7, Christiane Pott4, Anton W Langerak8, Patricia J T A Groenen7, Frederic Davi6, Monika Brüggemann4, Nikos Darzentas1.   

Abstract

Motivation: The study of immunoglobulins and T cell receptors using next-generation sequencing has finally allowed exploring immune repertoires and responses in their immense variability and complexity. Unsurprisingly, their analysis and interpretation is a highly convoluted task.
Results: We thus implemented ARResT/Interrogate, a web-based, interactive application. It can organize and filter large amounts of immunogenetic data by numerous criteria, calculate several relevant statistics, and present results in the form of multiple interconnected visualizations. Availability and Implementation: ARResT/Interrogate is implemented primarily in R, and is freely available at http://bat.infspire.org/arrest/interrogate/ Contact: nikos.darzentas@gmail.com Supplementary Information: Supplementary data are available at Bioinformatics online.

Mesh:

Substances:

Year:  2017        PMID: 28172348     DOI: 10.1093/bioinformatics/btw634

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  29 in total

Review 1.  Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?

Authors:  Michaela Kotrova; Jan Trka; Michael Kneba; Monika Brüggemann
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

2.  Immunoglobulin Gene Mutational Status Assessment by Next Generation Sequencing in Chronic Lymphocytic Leukemia.

Authors:  Anne Langlois de Septenville; Myriam Boudjoghra; Clotilde Bravetti; Marine Armand; Mikaël Salson; Mathieu Giraud; Frederic Davi
Journal:  Methods Mol Biol       Date:  2022

3.  Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq.

Authors:  Vincent H J van der Velden; Lorenz Bastian; Monika Brüggemann; Alina M Hartmann; Nikos Darzentas
Journal:  Methods Mol Biol       Date:  2022

4.  Purpose-Built Immunoinformatics for BcR IG/TR Repertoire Data Analysis.

Authors:  Chrysi Galigalidou; Laura Zaragoza-Infante; Anastasia Chatzidimitriou; Kostas Stamatopoulos; Fotis Psomopoulos; Andreas Agathangelidis
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Quality Control for IG /TR Marker Identification and MRD Analysis.

Authors:  Eva Fronkova; Michael Svaton; Jan Trka
Journal:  Methods Mol Biol       Date:  2022

6.  ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights.

Authors:  Nikos Darzentas
Journal:  Methods Mol Biol       Date:  2022

7.  Immunoglobulin/T Cell Receptor Capture Strategy for Comprehensive Immunogenetics.

Authors:  James Peter Stewart; Jana Gazdova; Shambhavi Srivastava; Julia Revolta; Louise Harewood; Manisha Maurya; Nikos Darzentas; David Gonzalez
Journal:  Methods Mol Biol       Date:  2022

8.  cfDNA-Based NGS IG Analysis in Lymphoma.

Authors:  Christiane Pott; Michaela Kotrova; Nikos Darzentas; Monika Brüggemann; Mouhamad Khouja
Journal:  Methods Mol Biol       Date:  2022

Review 9.  MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.

Authors:  Manuela Tosi; Orietta Spinelli; Matteo Leoncin; Roberta Cavagna; Chiara Pavoni; Federico Lussana; Tamara Intermesoli; Luca Frison; Giulia Perali; Francesca Carobolante; Piera Viero; Cristina Skert; Alessandro Rambaldi; Renato Bassan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

10.  TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients.

Authors:  Jorn L J C Assmann; P Martijn Kolijn; Benjamin Schrijver; Adriaan J van Gammeren; Daan W Loth; Ton A A M Ermens; Willem A Dik; Vincent H J van der Velden; Anton W Langerak
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.